A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated allergoid Dactylis glomerata/Phleum pratense administered subcutaneously to patients with grass pollen-induced allergic rhinitis or rhinoconjunctivitis.
Not yet recruitingCTIS2025-524580-21-00
Inmunotek S.L.Grass pollen induced allergic rhinitis or rhinoconjunctivitis
Target: 450Updated: 2026-05-29